VINNO Portable Ultrasound at Novo Nordisk (China) Pharmaceuticals Co.


Release time:

2019-03-06

Novo Nordisk (China) Pharmaceutical Co., Ltd. was established in 1994 and was the first biopharmaceutical company to set up an R&D center in China.

Novo Nordisk is the world's leading biopharmaceutical company committed to human health and advanced biotechnology for the benefit of patients, physicians and society, and has been a world leader in the treatment of diabetes for more than 80 years through its research and development capabilities.

 

 

March 6, 2019, Beijing - Novo Nordisk China R&D Center announced the launch of the INNOVO platform, which joins hands with local biopharmaceutical innovation forces through an open innovation model to actively contribute to Beijing's accelerated collaborative innovation initiatives in medicine and health.

 

 

At this time, it is an honor and a great encouragement for us that the products and services of VINNO - YEERAN are recognized by the world's leading pharmaceutical companies.